Rituximab and Combination Chemotherapy Combined With Yttrium Y 90 Ibritumomab Tiuxetan in Treating Older Patients With Previously Untreated B-Cell Lymphoma
PHASE2
RATIONALE: Monoclonal antibodies such as rituximab and yttrium Y 90 ibritum...
A Randomized Study of Iodine-131 Anti-b1 Antibody Versus Anti-b1 Antibody in Chemotherapy-relapsed/Refractory Low-grade or Transformed Low-grade Non-Hodgkin's Lymphoma (NHL)
PHASE2
Subjects were randomized to receive either tositumomab (Anti-B1 Antibody) a...
A Study on Exploring the Abscopal Effect Induced by Different Radioimmunotherapy Combination Patterns in the Treatment of Non-Small Cell Lung Cancer With Multiple Metastases
PHASE2
It is planned to carry out a multicenter umbrella study to find the optimal...
Status
Recruiting
Location
the second affiliated hospital of Army medical university